Clinical Trials
4 trialsNCT07247058 2026-03-05
Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Johns Hopkins University
Phase 4 Recruiting
NCT07104812 2026-02-11
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Mayo Clinic
Phase 2 Recruiting
NCT07247162 2025-12-10
LINC CARE
RECORDATI GROUP
Phase 4 Not yet recruiting
NCT02468193 2020-05-06
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Novartis
Phase 2 Completed